Monoclonal antibody matrix metalloproteinase-1 patent granted
Summary
USPTO granted Patent US12595315B2 to S&T BIOMED CO., LTD. for a monoclonal antibody specific to matrix metalloproteinase-1. The patent covers the antibody's heavy and light chain variable regions with specific CDR sequences, along with polynucleotides, detection kits, and detection methods. This grant date is April 7, 2026.
What changed
The USPTO granted Patent US12595315B2 to S&T BIOMED CO., LTD. covering a monoclonal antibody targeting matrix metalloproteinase-1 (MMP-1). The patent protects the antibody's heavy and light chain variable regions with defined CDR sequences, along with associated polynucleotides, detection kits, and detection methods.
For entities conducting MMP-1 related research or developing diagnostic applications, this patent grant establishes intellectual property protection that may require licensing or design-around strategies to avoid infringement during commercialization efforts.
What to do next
- Monitor for updates
Archived snapshot
Apr 7, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Monoclonal antibody of matrix metalloproteinase-1, detection kit and detection method thereof
Grant US12595315B2 Kind: B2 Apr 07, 2026
Assignee
S&T BIOMED CO., LTD.
Inventors
Ya-Ting Chang, Jau-Song Yu, Jun-Sheng Wang, Shu-Fang Wu, Chih-Ju Chen, Yen-Chun Liu
Abstract
Provided is a monoclonal antibody of matrix metalloproteinase 1. The monoclonal antibody has a heavy chain variable region with an amino sequence comprising i) CDR1 selected from the group consisting of SEQ ID NOs: 1, 7 and 13, ii) CDR2 selected from the group consisting of SEQ ID NOs: 2, 8 and 14, and iii) CDR3 selected from the group consisting of SEQ ID NOs: 3, 9 and 15. The monoclonal antibody also has a light chain variable region with an amino sequence comprising i) CDR1 selected from the group consisting of SEQ ID NOs: 4, 10 and 16, ii) CDR2 selected from the group consisting of SEQ ID NOS: 5, 11 and 17, and iii) CDR3 selected from the group consisting of SEQ ID NOs: 6, 12 and 18. A polynucleotide, a detection kit and a detection method are also provided as well.
CPC Classifications
C07K 16/40 C07K 2317/565 G01N 33/54387
Filing Date
2020-02-27
Application No.
17791744
Claims
12
Related changes
Get daily alerts for USPTO Patent Grants - Peptides (C07K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Grants - Peptides (C07K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.